# Cardiff Oncology, Inc.: Form 10-Q for the period ended Sep 30, 2026

- Company: [Cardiff Oncology, Inc.](/companies/crdf.md) (CIK 1213037)
- Form: 10-Q
- Filed: 2026-11-12
- Accepted by EDGAR: Nov 12, 2026, 16:20 ET
- Period: 2026-09-30
- Accession: 0001193125-26-458485
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1213037/000119312526458485/crdf-20260930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1213037/000119312526458485/

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1213037/000119312526458485/crdf-20260930.htm

Filed Nov 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-458485. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
